Clinical Trials on Light Chain (AL) Amyloidosis in United Kingdom
Total 106 results
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
Nexcella Inc.Not yet recruitingLight Chain (AL) AmyloidosisUnited States
-
Sorrento Therapeutics, Inc.RecruitingLight Chain (AL) AmyloidosisUnited States
-
Prothena Biosciences Ltd.RecruitingLight Chain (AL) AmyloidosisUnited States, Korea, Republic of, Australia, Denmark, France, Italy, Spain, Israel, Taiwan, Austria, Canada, Czechia, Germany, Greece, Hungary, Japan, Netherlands, Poland, Portugal, Turkey, United Kingdom, Belgium, Ireland
-
IRCCS Policlinico S. MatteoTerminatedCardiac AL AmyloidosisSpain, France, Italy, Germany, Canada, Greece, Turkey, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
Life Molecular Imaging GmbHpharmtrace klinische Entwicklung GmbHRecruitingAL Amyloidosis | Cardiac Amyloidosis | ATTR AmyloidosisUnited States, Spain, Germany, United Kingdom
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingAL Amyloidosis | Amyloid | Refractory AL AmyloidosisUnited States
-
Marianna FontanaRecruitingExploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders (EXACLIBUR)Sudden Cardiac Death | Arrythmia | Cardiac Amyloidosis | Systemic AL AmyloidosisUnited Kingdom
-
European Myeloma NetworkCompletedAL AmyloidosisNetherlands, Czechia, Austria, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompleted
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
Prothena Biosciences Ltd.TerminatedAL AmyloidosisUnited States, Spain, Australia, Italy, Germany, Austria, Greece, France, Israel, United Kingdom
-
Tufts Medical CenterTerminatedAL AmyloidosisUnited States
-
Mayo ClinicRecruitingAL AmyloidosisUnited States
-
Columbia UniversityCephalonCompletedAL AmyloidosisUnited States
-
Boston Medical CenterSpectrum Pharmaceuticals, IncTerminatedAmyloidosis; SystemicUnited States
-
University College, LondonCompleted
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Andrew EisenbergerCompletedAmyloidosisUnited States
-
University of TennesseeFood and Drug Administration (FDA)Completed
-
Prothena Biosciences Ltd.TerminatedAL AmyloidosisUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
University of TennesseeCompleted
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
K-Group Alpha, Inc., a wholly owned subsidiary...Active, not recruitingAL Amyloidosis | AmyloidosisSpain, Australia, Israel, United States, Greece, Italy, Cyprus
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawnAL Amyloidosis | Amyloidosis | AmyloidUnited States
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterVanderbilt University Medical Center; Tufts Medical CenterActive, not recruiting
-
National Cancer Institute (NCI)Recruiting
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Prothena Biosciences Ltd.Amyloidosis Research Consortium; Amyloidosis Support Groups; Amyloidosis Foundation and other collaboratorsCompletedAL Amyloidosis | AmyloidosisUnited States
-
M.D. Anderson Cancer CenterCelgeneTerminatedMyelomaUnited States
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Midwest Heart & Vascular SpecialistsRecruitingAL Amyloidosis | Amyloid | Cardiac Amyloidosis | Amyloidosis Cardiac | Systemic Amyloidosis | ATTR Amyloidosis Wild Type | Infiltrative Cardiomyopathy, AmyloidUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States